Clinical Trial Results:
PROSPECTIVE, RANDOMIZED, OPEN-LABEL, MULTICENTRE,ACTIVE DRUG CONTROLLED, PARALLEL GROUP DESIGN CLINICAL TRIAL OF THE EFFICACY AND SAFETY OF BECLOMETHASONE DIPROPIONATE 400 MCG FORMOTEROL 24 MCG FOSTER PMDI VIA HFA-134A VS. FLUTICASONE PROPIONATE 500 MCG SALMETEROL XINAFOATE 100 MCG DPI SERETIDE DISKUS IN THE 6 MONTHS STEP DOWN TREATMENT OF ADULT PATIENTS WITH CONTROLLED ASTHMA
Summary
|
|
EudraCT number |
2006-005349-13 |
Trial protocol |
IT ES BG |
Global completion date |
29 Mar 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
06 Jan 2017
|
First version publication date |
06 Jan 2017
|
Other versions |
|
Summary report(s) |
EudraCT No. 2006-005349-13 Medical Journal Article |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.